Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of two permethrin cream concentrations for scabies
2023-507925-41-00Phase 3Authorised
- Sponsor
- InfectoPharm
- Start
- Jul 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of permethrin in scabies (2 arms), sponsored by InfectoPharm. Primary endpoint: Clinical efficacy after completion of treatment. Planned start Jul 2024; status: authorised.
02
Drugs
permethrin
03
Conditions
scabies
Beyond the preview
Go deeper on 2023-507925-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507925-41-00.